Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Invested Capital: 2024-2025

  • Tg Therapeutics' Return on Invested Capital was N/A to 0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.31%, marking a year-over-year change of. This contributed to the annual value of 0.16% for FY2024, which is 3.00% up from last year.
  • Latest data reveals that Tg Therapeutics reported Return on Invested Capital of 0.31% as of Q2 2025, which was up 25.20% from 0.24% recorded in Q1 2025.
  • In the past 5 years, Tg Therapeutics' Return on Invested Capital ranged from a high of 0.31% in Q2 2025 and a low of 0.18% during Q4 2024.
  • Its 2-year average for Return on Invested Capital is 0.24%, with a median of 0.24% in 2025.